SANTA ANA, CA--(NewMediaWire - Mar 28, 2016) - ADVANTIS
CORPORATION (OTC
PINK: ADVT) CEO, Chris Swartz, described the future growth
prospects for the company and announced the launch of LipMedRX on a
global scale.
Swartz emphasized that former CEO, Jeremy Foti, laid the solid
foundation necessary to direct the company toward distributing
products that help people take control of their health. "All the
products he (Foti) focused on delivering to the public revolve
around health and pain management," Swartz said, "Clean VD lets
people assess their sexual health, LipMedRX provides protection
against the flu and other viruses, and cannabis contains natural
compounds that are proven to eliminate pain and reduce inflammation
in the body." Swartz sees commonality in all these health-related
products, citing legitimate studies confirming that the natural
chemical compounds found within the cannabis plant have significant
therapeutic and anti-inflammatory properties.
Swartz said he envisions the success of Advantis Corp. through
strengthened partnerships, innovative product development, and a
sustained focus on revenue-producing strategies. "We are launching
LipMedRX globally today on Amazon, to provide this revolutionary
new lip balm to the world; we plan on doing the same thing with
Clean VD, both of which will produce sustained revenues over time."
Swartz put these developments in the context of efforts toward his
primary goal, saying, "These ventures will develop immediate
revenue, while our efforts to further partnerships and agreements
with those that produce and distribute cannabis and its extracts is
a more deliberate and exacting process." As a publicly traded
company, federal laws prohibit the company from taking direct
profit from certain production and distribution processes, however
Swartz says that those laws do not prohibit the company from
supplying certain products and consulting activities to the
industry. "We are committed to working effectively through
partnerships that legally supply cannabis in their respective
states; our current relationships give us an advantage in the way
of agricultural knowledge and operational efficiencies that allow
us to benefit from the business, while helping to power it," Swartz
passionately related.
Swartz's background in treating chronic pain and delivering
holistic solutions gives him a unique insight into how to bridge
the gap between currently accepted pain management techniques and
the future of the industry. "Medical cannabis treats several
conditions beyond chronic pain," he said, "and I have seen first
hand how, when given the chance to self-medicate, that those in
pain are able to free themselves from addictive painkillers and
anti-inflamatories, and find a more beneficial, organic solution
with CBD and THC extracts. Everyone should have access to these
benefits, and it should not be constrained by an outdated law that
had nothing to do with effective healthcare." Swartz reiterated his
commitment to working within the law to change it, and emphasized
that while he feels strongly about his purpose within the company,
revenue is the end result. "I thrive on creating win-win
scenarios," Swartz stated, "and the only way to bring my vision to
fruition is through revenue growth and sustainability... the means
that justify the ends."
Swartz stated that while LipMedRx is going global today and can
now be purchased on Amazon, CleanVD should be fully launched by the
end of the 2nd quarter. Priority projects such as his app-based
pain management technology solution that has already been tested by
orthopedic surgeons, chiropractors, and senior care providers, will
also be launched within the 2nd quarter. Ongoing development
operations related to the Oregon, Washington and California
marijuana markets will only be announced as operational security is
confirmed.
ABOUT Advantis Corporation
Advantis Corporation (ADVT)
focuses on the development of innovative products that supply the
medical, research, and pharmaceutical industries. The company
additionally establishes domestic and international partnerships
with businesses that develop and sell proprietary consumer products
and services. Product lines for consumer health care, music and
entertainment sectors are in development.
Forward Looking Statements: This news release contains
forward-looking statements made by ADVANTIS CORPORATION. All such
statements included in this press release, other than statements of
historical fact, are forward-looking statements. Although
management believes that the expectations reflected in such
forward-looking statements are reasonable, it can give no assurance
that such expectations will prove to have been correct. Actual
results may differ materially from those indicated by these
statements. The following risk factors, among others, could cause
actual results to differ materially from those described in any
forward- looking statements. These risks and uncertainties include,
but are not limited to, economic conditions, changes in the law or
regulations, demand for products of the Company, the effects of
competition and other factors that could cause actual results to
differ materially from those projected or represented in the
forward looking statements. Forward-looking statements are
typically identified by the words: believe, expect, anticipate,
intend, estimate, and similar expressions or which by their nature
refer to future events. The Company is not entitled to rely on the
safe harbor provisions of Section 27A of the Securities Act of 1933
and Section 21E of the Securities Exchange Act of 1934 because it
is not registered under either Act.